Objective: To study the temporal distribution and causes of hospitalizations after heart failure (HF) diagnosis. Patients and Methods: Hospitalizations were studied in 1972 Olmsted County, Minnesota, residents with incident HF from January 1, 2000, to December 31, 2011. All hospitalizations were examined for the 2 years following incident HF, and each was categorized as due to HF, other cardiovascular causes, or noncardiovascular causes. Negative binomial regression examined associations between time periods (0-30, 31-182, 183-365, and 366-730 days after diagnosis) and hospitalizations. Results: During the 2 years after diagnosis, 3495 hospitalizations were observed among 1336 of the 1972 patients with HF. The age-and sex-adjusted rates of hospitalizations were highest in the first 30 days after diagnosis (3.33 per person-year vs 1.33, 1.07, and 1.00 per person-year for 31-182 days, 183-365 days, and 366-730 days, respectively). The rates of hospitalizations were similar across sex, presentation of HF (inpatient or outpatient), and type of HF (preserved or reduced ejection fraction). Patients diagnosed as inpatients who had long hospital stays (>5 days) experienced more than a 30% increased risk of rehospitalization within 30 days of dismissal. Importantly, most hospitalizations (2222 of 3495 [63.6%]) were due to noncardiovascular causes, and a minority (440 of 3495 [12.6%]) were due to HF. The rates of noncardiovascular hospitalizations were higher than those for HF or other cardiovascular hospitalizations across all follow-up for all time periods after HF. Conclusion: Patients with HF experience high rates of hospitalizations, particularly within the first 30 days, and mostly for noncardiovascular causes. To reduce hospitalizations in patients with HF, an integrated approach focusing on comorbidities is required. 
H eart failure (HF) is a major clinical and public health concern. The aging population and improved survival have led to the continued increase in HF prevalence, as well as the resulting high burden of hospitalizations and health care costs among individuals with HF. 1 Notably, the course of HF is characterized by clinical exacerbations leading to hospitalizations. 2 As such, the Hospital Readmissions Reduction Program, created under the Affordable Care Act, requires the Centers for Medicare and Medicaid Services to reduce payments to hospitals with excess 30-day readmissions for HF. Most prior studies assessing rates of hospitalization in HF have included only patients with an initial hospitalization for HF, thus pooling incident and prevalent HF and missing patients diagnosed in the outpatient setting. [3] [4] [5] There is a paucity of data describing rates of hospitalizations over the course of the HF syndrome after the initial diagnosis of HF, including patients who were diagnosed as outpatients. In addition, most studies have a short follow-up of 30 days 5 or 1 year 4, 6 after the index event. Thus, there is insufficient data to determine whether the first 30 days are the most important time frame for increased risk of hospitalization after HF diagnosis.
In addition, a change in the case mix over the past decade has resulted in an increased proportion of HF with preserved ejection fraction (EF). 7 These recent community data suggest that the shift in case mix has resulted in an increase in hospitalizations for noncardiovascular causes. 7 This shift has profound implications for patients and clinicians, yet a full understanding of the patterns and distributions of types of hospitalizations over the course of the HF syndrome and whether these patterns are affected by EF remains largely unknown. The goal of this study was to address the aforementioned gaps in knowledge by examining the patterns of hospitalizations over the course of the HF syndrome, identifying whether there are periods of increased vulnerability to hospitalizations, and assessing how these patterns may differ according to the case mix of HF (preserved or reduced EF) in a geographically defined community cohort of patients with HF.
PATIENTS AND METHODS

Study Population
This study was conducted in Olmsted County, Minnesota, utilizing the resources of the Rochester Epidemiology Project, a records linkage system allowing virtually complete capture of health care utilization and outcomes in county residents. [8] [9] [10] [11] The retrieval of nearly all health careerelated events occurring in Olmsted County is possible because this area is relatively isolated from other urban centers, and few health care facilities, including Mayo Clinic, Olmsted Medical Center, and their affiliated hospitals, deliver most health care to local residents. The demographic and ethnic characteristics of Olmsted County residents are representative of the state of Minnesota and the Midwest region of the United States. 9 Furthermore, broad disease trends and age-and sex-specific mortality rates in Olmsted County are similar to national data. 9 This study was approved by the Mayo Clinic and Olmsted Medical Center institutional review boards.
Identification of the Incident HF Cohort
Heart failure diagnoses among Olmsted County residents between January 1, 2000, and December 31, 2011, were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 428 assigned during either an outpatient visit or a hospitalization. 12, 13 A random sample of 50% of the HF diagnoses assigned between January 1, 2000, and December 31, 2006, was selected and reviewed; all of the HF diagnoses assigned from January 1, 2007, to December 31, 2011, were reviewed. Heart failure diagnoses were validated by trained nurse abstractors using the Framingham Heart Study diagnostic criteria, 14 and incidence status was determined after review of the entire medical record, which, on average, spanned 4 decades. 15 Patients with prevalent HF were excluded.
Clinical Data Collection
Clinical notes were reviewed to abstract height, weight, and smoking status at the time of incident HF. Body mass index was calculated as weight in kilograms divided by height in meters squared. Comorbidities were ascertained electronically by retrieving inpatient and outpatient diagnostic codes and requiring at least 2 occurrences of a code (either the same code or 2 different codes within the same code set) within the 5 years before incident HF. The code sets were based on a modification of the Charlson Comorbidy Index 16, 17 and were validated against manually abstracted data in 1418 patients with incident HF (Supplemental Table, 18 Left ventricular EF (LVEF) (%) was determined using values collected from any echocardiogram, angiogram, multigated acquisition scan, or technetium Tc 99m sestamibi scan performed within 3 months of the incident HF date. When multiple values were available, the value closest to the HF date was used; the average was used when multiple values were measured on the same day. Heart failure with preserved EF was defined as an LVEF of greater than or equal to 50%, while HF with reduced EF was defined as an LVEF of less than 50%. 19 Outcomes Ascertainment All hospitalizations occurring within the 2 years following incident HF were obtained from the Rochester Epidemiology Project. The principal discharge diagnosis for each hospitalization was identified, and each hospitalization was categorized as due to HF (ICD-9-CM code 428), other cardiovascular causes (ICD-9-CM codes 390-427, 429-459), or noncardiovascular causes.
Statistical Analyses
Analyses were performed using SAS statistical software, version 9.4 (SAS Institute Inc). Characteristics of the patients with HF are provided as means and frequencies. Follow-up after the incident date of HF was divided into discrete time periods (epochs): 0-30 days, 31-182 days, 183-365 days, and 366-730 days. For patients who were hospitalized at incident HF, the date of discharge from the hospital was considered day 0. A likelihood ratio test revealed that overdispersion was present in the Poisson regression model; thus, negative binomial regression was used to estimate rates and rate ratios of hospitalizations by epochs of followup time. In addition, to assess the impact of survivor bias on the rates of hospitalization per epoch of follow-up time, a random effects generalized linear mixed model was run. The parameter estimates and rate ratios from the random effects model were nearly identical to estimates from the negative binomial model; thus, the negative binomial results are presented. Rates and rate ratios are presented overall, by sex, by presentation at incident HF (inpatient or outpatient), and by type of HF (preserved EF or reduced EF). In addition, separate negative binomial models were run to estimate rates and rate ratios by epochs of follow-up time for different types of hospitalization (due to HF, due to other cardiovascular causes, and due to noncardiovascular causes). Finally, Cox proportional hazards regression models were used to determine predictors of hospitalization within the first 30 days after adjustment for age and sex. P¼.05 was considered statistically significant.
RESULTS
Among the 1972 patients with incident HF (mean age, 76.3 years, 871 [44.2%] male), 1344 (68.2%) were hospitalized at index (Table 1) . Seven hundred thirty of the 1574 who had EF measured (46.4%) had an EF of less than 50%. Over the 2-year follow-up, 3495 hospitalizations were observed among 1336 patients, and 427 patients (32.0%) were hospitalized within 30 days of incident HF. Among those hospitalized within 30 days, the median time from HF to hospitalization was 9 days. The age-and sex-adjusted rates of hospitalizations were highest in the first 30 days after index (3.33 per personyear) and much lower thereafter (1.33, 1.07, and 1.00 per person-year for 31-182 days, 183-365 days, and 366-730 days, respectively; Table 2 ). No differences were observed between men and women, those who presented with incident HF as inpatients or outpatients, and those with preserved or reduced EF.
After adjusting for demographic characteristics and comorbidities, the rate ratios for hospitalizations were significantly lower for the later time periods compared with the first 30 days (Table 3) . Overall, compared with the first 30 days after HF, the rate ratios (95% CIs) were 0.39 (0.35-0.45), 0.32 (0.28-0.36), and 0.29 (0.26-0.33) for 31-182 days, 183-265 days, and 366-730 days after HF index, respectively. The rate ratios were similar across sex, presentation, and HF type.
After adjustment for age and sex, the following comorbidities were predictive of hospitalization within the first 30 days: prior After adjustment for demographic characteristics and comorbidities, the rate ratios for hospitalizations due to HF and other cardiovascular conditions were similar, whereas higher rate ratios were observed for noncardiovascular hospitalizations for all time periods (Table 5) .
DISCUSSION
This contemporary community study of patients with incident HF described the burden and timing of hospitalizations occurring over the 2 years following the diagnosis of HF. We found that the rates of hospitalization were highest during the first 30 days and much lower thereafter and did not differ by sex, type of HF (preserved vs reduced EF), or presentation (inpatient vs outpatient). Patients with myocardial infarction, chronic pulmonary disease, cancer, and dementia, as well as those diagnosed with HF as inpatients who had long hospital stays (>5 days) had an increased risk of being hospitalized within 30 days. Although the proportions of hospitalizations due to HF or other cardiovascular causes were highest during the first 30 days, more than half of all hospitalizations were due to noncardiovascular causes and few were due to HF.
Hospitalizations in Patients With HF
Frequent hospitalizations represent a major burden for patients with HF and health care systems. Although contemporary data on the epidemiology of HF are scarce, data from more than a decade ago indicate that the incidence of HF remained largely stable over time. 13, 20, 21 In addition, these older data indicate increasing HF incidence among older persons, 13, 20, 22 gradually displacing the burden of the HF syndrome toward older individuals. Furthermore, improvement in survival 13, 20, 22 has increased the number of elderly survivors with prevalent HF who are candidates for recurrent hospitalizations.
Contemporary community data from Olmsted County suggest an overall decline in HF incidence between 2000 and 2010 with a change in the case mix toward an increasing proportion of patients with preserved EF in recent years. 7 A decline over time in HFspecific hospitalization rates among Medicare beneficiaries has also been observed, although patients with HF treated in the outpatient setting were not captured. 23, 24 Nevertheless, evidence suggests that the frequency of all-cause hospitalizations in patients with HF has not declined over time, 25 but the shift in case mix toward increasing proportions of patients with preserved EF has resulted in an increase in hospitalizations for noncardiovascular causes. 7 This information, in combination with the observations that patients with HF and preserved EF have a higher burden of comorbidities than those with reduced EF 26, 27 and that most hospitalizations in patients with HF are not attributed to HF, 12 suggests that the HF syndrome is characterized by an epidemic of hospitalizations.
Timing of Hospitalizations After HF
Although there is convincing evidence that patients with HF are experiencing an epidemic of hospitalizations, previous studies assessing whether this burden of hospitalizations differs according to the timing after HF diagnosis have limitations. Indeed, restriction to only hospitalized patients with HF, including both incident and prevalent cases, capturing only cardiovascular hospitalizations, and counting only the first hospitalization occurring during follow-up all substantially limit inference. Among Medicare patients, readmissions within the first 30 days after an HF hospitalization were common, the majority occurred within the first 15 days (median of 12 days), and the minority were due to HF (35%). 5 In addition, the overall pattern of diagnoses responsible for readmission did not differ over time or by patient demographic characteristics. 5 Similarly, we observed a median time to 30-day readmission of 9 days and no differences in the burden of hospitalizations by sex. However, we found a markedly lower proportion of 30-day hospitalizations attributed to HF (16.6%), which may reflect differences in the patient populations or ascertainment relying on clinical data rather than claims data. Our study identified patients at the time of incident HF diagnosis, included all patients (those diagnosed as inpatients and outpatients), and captured all hospitalizations after HF diagnosis, whereas the aforementioned study excluded outpatients and captured only the first rehospitalization within 30 days.
Another study among Medicare beneficiaries with a hospitalization for HF were followed up to 1 year until the first hospitalization for any cause, reported the highest rates of readmission early with continued reduction in the rates over time for the first year. 4 A study utilizing a large commercial insurance database, OptumLabs, followed patients with incident HF (inpatients or outpatients) for 1 year for all hospitalizations and reported the highest rates of hospitalizations within the first 30 days and 13% of hospitalizations within the first year being due to HF. 6 In the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program, the majority of hospitalizations over a median of 9.9 months of follow-up were due to cardiovascular causes, with 46% due to HF; however, this study only enrolled patients hospitalized with worsening HF and EF of 40% or less, which likely explains the much higher proportion of hospitalizations due to HF observed in this study. 28 Finally, patients hospitalized for HF and enrolled in phase 1 of the Enhanced Feedback for Effective Cardiac Treatment (EF-FECT) study were followed up over their lifetime, revealing 2 periods of increased hospitalizations: within the first and last decile Rate ratios are adjusted for age, sex (except sex-specific models), body mass index, hypertension, diabetes, prior myocardial infarction, chronic pulmonary disease, cerebrovascular disease, peripheral vascular disease, renal disease, liver disease, hemiplegia, metastatic and nonmetastatic cancers (excluding nonmelanoma skin cancers), estimated glomerular filtration rate, and smoking status. c P for interaction. of survival duration, which given the median survival of 1.8 years corresponds roughly to the first 2 months after hospital discharge and the last 2 months before death. 3 Our study followed patients with incident HF for 2 years after their first diagnosis of HF (not restricted to hospitalized HF), and we similarly observed differences over time in the rates of hospitalizations with an increased vulnerability for hospitalizations during the first 30 days after the diagnosis of HF. We also found that the rates of hospitalizations over time did not differ by type of HF (preserved vs reduced EF). Similar to the OptumLabs study, we also observed that 13% of all hospitalizations occurring over the 2-year follow-up were due to HF; however, our study identified a higher proportion (16.6%) of HF-specific hospitalizations during the first 30 days after the diagnosis of HF. Nevertheless, we observed that a very small proportion of hospitalizations were due to HF, and 63.6% were due to noncardiovascular causes.
Because the majority of hospitalizations ocurring in patients with HF are due to noncardiovascular causes, increased focus on management of noncardiovascular conditions in patients with HF may help reduce the rates of hospitalizaiton in these patients. Within the first 30 days after diagnosis of HF, we identified few predictors of hospitalization, with prior myocardial infarction being the only FIGURE. Age-and sex-adjusted predictors of hospitalization within the first 30 days after incident heart failure. The estimate for age is adjusted for sex, and the estimate for sex is adjusted for age; all other estimates are adjusted for age and sex. eGFR ¼ estimated glomerular filtration rate.
cardiovascular comorbidity that was predictive of hospitalization within 30 days. The remaining predictors were noncardiovascular conditions, including chronic pulmonary disease, cancer, and dementia. Not surprisingly, patients who were initially diagnosed with HF as inpatients and who had long hospital stays were also at an increased risk of rehospitalization within 30 days. Taken collectively, our findings highlight the importance of identifying more comprehensive interventions for patients with HF to reduce the burden of hospitalizations in these patients.
Clinical Implications
One-third of patients with HF are hospitalized within 30 days of diagnosis, with similar rates across HF types (preserved vs reduced EF) and presentation (diagnosed as an inpatient vs outpatient). Importantly, the minority of hospitalizations are due to HF, with nearly two-thirds due to noncardiovascular causes. Thus, screening and aggressive management of comorbidities should be routine in these patients. Indeed, interventions targeting comorbidities in patients with HF may be more effective at preventing hospitalizations than HF-specific interventions. Furthermore, because patients diagnosed with HF as outpatients are at a similar risk of hospitalization as those who present as inpatients, interventions to reduce hospitalizations should not focus solely on hospitalized patients but should be targeted to all patients with HF.
Limitations and Strengths
The following limitations should be considered when interpreting our study results. Some hospitalizations occurring outside Olmsted County may have been missed; however, we expect that any missing hospitalizations were minimal because Olmsted County is relatively isolated and the majority of health care for residents is provided by the few medical centers within the county. Although we used only the principal discharge diagnosis code to classify the types of hospitalization, some misclassification for the types of hospitalization may have occurred because of coding practices or inaccuracies in assigning codes.
Our study also has several strengths. In particular, we have captured the experience of community patients with HF, including those diagnosed as inpatients and outpatients, without restriction on type of HF (preserved or reduced EF), age, or insurance status or Medicare enrollment. Furthermore, all hospitalizations occurring over a long follow-up (2 years) were included, providing a more comprehensive description of the burden of hospitalizations over the course of the HF syndrome.
CONCLUSION
Patients with HF experience a large burden of hospitalizations. The rates of hospitalizations are highest within the first 30 days after diagnosis, and most hospitalizations are due to noncardiovascular causes. Because a minority of hospitalizations are due to HF, employing integrated interventions, including improved management of comorbid conditions, will be more effective at reducing hospitalizations than interventions focused solely on HF.
